GI Support Discussion Protocol

🫁 GI Support Protocol

Back to Library
🫁

GI Support

GI Support Discussion Protocol

Educational protocol for gastrointestinal health research discussions

Moderate Risk ProfileintermediateLow Evidence
Research Information

This protocol is provided for educational and informational purposes only. It does not constitute medical advice, a diagnosis, a treatment plan, or a prescription.

All dose ranges, frequencies, durations, and compound selections must be determined by a licensed healthcare professional based on your individual medical history, lab results, and clinical assessment.

Lab monitoring may be required depending on the compound(s), individual health status, and duration of use. Discuss appropriate monitoring protocols with your clinician.

Do not use any peptide compound if you are pregnant, breastfeeding, a minor, or have uncontrolled medical conditions without explicit direction from your physician.

Overview

This protocol provides structured discussion points for individuals with clinician-documented GI conditions who are exploring research compounds associated with gut mucosal integrity and GI inflammation.

Mechanism Summary

GI-support compounds in this category are explored for their potential effects on gut barrier function, mucosal healing, and inflammatory cytokine modulation. BPC-157 has extensive preclinical data in GI healing models.

Intended Goal

Prepare for a clinician discussion about GI-focused peptide research

GI / tissue repair / anti-inflammatory

Widely studied in GI contexts including gut barrier function. Catalog reference only.

Anti-inflammatory / GI mucosal support

Alpha-MSH fragment studied for intestinal inflammation. Catalog reference only.

Protocol calculator: All compounds shown together. Set each vial size, BAC water added, and your intended dose — the draw units update instantly for every peptide in this protocol. Defaults are placeholders — adjust to your actual vials and clinician instructions.
BPC-157GI / tissue repair / anti-inflammatory
Draw
10
units
Conc
2500
mcg/mL
Vol
0.1
mL
Doses/vial
20
inj.
KPVAnti-inflammatory / GI mucosal support
Draw
10
units
Conc
2500
mcg/mL
Vol
0.1
mL
Doses/vial
20
inj.

Research reference values only. Confirm all parameters with current literature and your clinician.

Who may be a candidate

  • Adults with clinician-managed IBD, IBS, or leaky gut concerns
  • Individuals exploring adjunct GI support after failure of standard therapies
  • Those under active gastroenterology care

Exclusions

  • Not a replacement for prescribed GI medications or specialist care
  • Not appropriate without gastroenterology evaluation for significant GI symptoms
1

Have I had the appropriate GI workup for my symptoms?

2

Is there a role for research compounds alongside my current GI treatment?

3

What form (oral or subcutaneous) would be most appropriate?

4

How would you track whether it's helping or causing harm?

Print or copy these questions using the "Copy Summary" button to bring to your appointment.

Legal & Compliance Notice

BPC-157 is a research compound. Verify regulatory status in your jurisdiction with a licensed clinician.

The legal and regulatory status of research compounds varies by country and jurisdiction. It is the user's responsibility to understand applicable local laws before engaging with any compound.

This application does not provide personalized dosing recommendations. Users who require medical guidance should consult a qualified clinician.

Last reviewed: 2025-01-15 · Status: reviewed

Discuss with Your Clinician

Use this protocol as a research starting point. A qualified healthcare professional can review your health history, order appropriate labs, and help you determine what approach — if any — makes sense for your specific situation.

Bring this protocol to your appointmentUse the questions below as a discussion guide